相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adoptive T Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cytomegalovirus Disease in a Renal Transplant Recipient
N. Macesic et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Regulation of advanced therapy medicinal products in Europe and the role of academia
Kim F. Pearce et al.
CYTOTHERAPY (2014)
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
Anastasia Papadopoulou et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Cytomegalovirus infection in liver transplant recipients: Updates on clinical management
Jasmine Riviere Marcelin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs
Mohamed Abou-El-Enein et al.
CYTOTHERAPY (2013)
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2013)
Prevention of cytomegalovirus following solid organ transplantation: A literature review
Shanna Kowalsky et al.
PEDIATRIC TRANSPLANTATION (2013)
Cytomegalovirus-Specific Regulatory and Effector T Cells Share TCR ClonalityuPossible Relation to Repetitive CMV Infections
S. Schwele et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Therapeutic strategies for the prevention and treatment of cytomegalovirus infection
Rob S. Sellar et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Human Cytomegalovirus-Specific T-Cell Immune Reconstitution in Preemptively Treated Heart Transplant Recipients Identifies Subjects at Critical Risk for Infection
Davide Abate et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Preferential Expansion of Human Virus-Specific Multifunctional Central Memory T Cells by Partial Targeting of the IL-2 Receptor Signaling Pathway: The Key Role of CD4+ T Cells
Michael Schmueck et al.
JOURNAL OF IMMUNOLOGY (2012)
Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive
Romaldas Maciulaitis et al.
MOLECULAR THERAPY (2012)
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2012)
Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients
Marta Bodro et al.
LIVER TRANSPLANTATION (2012)
Viral Infection in Renal Transplant Recipients
Jovana Cukuranovic et al.
SCIENTIFIC WORLD JOURNAL (2012)
Immunotherapy for EBV-associated malignancies
Anna Merlo et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Therapeutic options in post-transplant lymphoproliferative disorders
Heiner Zimmermann et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2011)
Antiviral Drug Resistance of Human Cytomegalovirus
Nell S. Lurain et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
T-cell therapy for cytomegalovirus infection
Tan S. Mui et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2010)
Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation
Donald R. Shaffer et al.
IMMUNOTHERAPY (2010)
Viral Impact on Long-term Kidney Graft Function
Ilkka Helantera et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation
E. Lapidus-Krol et al.
PEDIATRIC TRANSPLANTATION (2010)
Posttransplant Lymphoproliferative Disease in Liver Transplant Patients
Christina Hartmann et al.
Current Infectious Disease Reports (2010)
Adoptive T-Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy
G. Brestrich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Cytomegalovirus in Solid Organ Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Adenovirus infections in solid organ transplant recipients
Jill A. Hoffman
CURRENT OPINION IN ORGAN TRANSPLANTATION (2009)
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
Joseph F. Grosso et al.
JOURNAL OF IMMUNOLOGY (2009)
Generation of HCMV-specific T-cell Lines From Seropositive Solid-organ-transplant Recipients for Adoptive T-cell Therapy
Gordon Brestrich et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Adenoviruses in Immunocompromised Hosts
Marcela Echavarria
CLINICAL MICROBIOLOGY REVIEWS (2008)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Progressive telomere shortening of Epstein-Barr virus-specific memory T cells during HIV infection: Contributor to exhaustion?
Debbie van Baarle et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Prospective study of sequential reduction in immunosuppression, interferon alpha-2b, and chemotherapy for posttransplantation lymphoproliferative disorder
Lode J. Swinnen et al.
TRANSPLANTATION (2008)
Adoptive cellular immunotherapy for viral diseases
Y. Fujita et al.
BONE MARROW TRANSPLANTATION (2008)
Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells
Ananta Paine et al.
TRANSFUSION (2007)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders
M. K. Gandhi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD
Kathrin Sebelin-Wulf et al.
TRANSPLANT IMMUNOLOGY (2007)
CHOP-21 for the treatment of post-transplant lymphoproliferative disorders following solid organ transplantation
Sylvain Choquet et al.
HAEMATOLOGICA (2007)
Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction
Bianca Heemskerk et al.
JOURNAL OF IMMUNOLOGY (2006)
Treatment of solid organ transplant recipients with autologolus Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)
Barbara Savoldo et al.
BLOOD (2006)
Adenoviral infections in pediatric transplant recipients -: A hospital-based study
Marcela Hernandez de Mezerville et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
T Feuchtinger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients
TC Lee et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
M Cobbold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy
MH Hammer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-Specific T cells
P Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Cellular immunotherapy for viral infection after HSC transplantation
P Moss et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-γ secretion for adjuvant immunotherapy
T Feuchtinger et al.
EXPERIMENTAL HEMATOLOGY (2004)
CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection
JC Sun et al.
NATURE IMMUNOLOGY (2004)
Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease
DM Burns et al.
BLOOD REVIEWS (2004)
Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells
AM Leen et al.
BLOOD (2004)
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
MR Smith
ONCOGENE (2003)
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy
MA Sherritt et al.
TRANSPLANTATION (2003)
The impact of adenovirus infection on the immunocompromised host
T Kojaoghlanian et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
Epstein-Barr virus and post-transplant lymphoproliferative disease
RD Holmes et al.
PEDIATRIC TRANSPLANTATION (2002)
Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma
Q Sun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells
E Kondo et al.
JOURNAL OF IMMUNOLOGY (2002)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
H Einsele et al.
BLOOD (2002)
Infusion of autologous Epstein-Barr virus (EBV) -: specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
P Comoli et al.
BLOOD (2002)
Latency and reactivation of human cytomegalovirus
JGP Sissons et al.
JOURNAL OF INFECTION (2002)
Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir
RR Razonable et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Purification of cytomegalovirus-specific CD8 T cells from peripheral blood using HLA-peptide tetramers
RD Keenan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers
S Szmania et al.
BLOOD (2001)
Association of viral genome with graft loss in children after cardiac transplantation.
GS Shirali et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells
A Kleihauer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions
K Peggs et al.
BLOOD (2001)
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
VC Emery et al.
LANCET (2000)
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
H Einsele et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
